SCHEMBL4570732

SCHEMBL4570732

CC1(S(=O)(=O)c2ccc(Cl)cc2)CCN(c2nc(-c3ccccc3)ns2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.43
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
GBA1 P04062 1/20 0.36
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
KMT2A Q03164 1/20 0.35
RELA Q04206 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4570736 0.77 NEK2 (0.37) RAB9ANPC1MAPTLMNAKMT2A
SCHEMBL4570734 0.73 FAAH (0.45) FAAHCDK5CDK5R1ADORA3RAB9A
SCHEMBL15292124 0.67 FAAH (0.44) FAAHCDK5CDK5R1ADORA3RAB9A
SCHEMBL4570738 0.66 CNR2 (0.36) MAPTLMNAKMT2APSEN1PSEN2
SCHEMBL4570737 0.66 CNR2 (0.36) MAPTLMNAKMT2APSEN1PSEN2
SCHEMBL1785466 0.66 CNR2 (0.36) MAPTLMNAKMT2APSEN1PSEN2
SCHEMBL4570728 0.66 EEF2K (0.45) MAPTLMNAKMT2ANPSR1POLB
SCHEMBL1787389 0.65 CNR2 (0.43) MAPTLMNAMAPK1PSEN1PSEN2
SCHEMBL5405087 0.64 LMNA (0.61) ADORA3RAB9ANPC1LMNAKMT2A
SCHEMBL17101963 0.62 ALDH1A1 (0.53) RAB9ANPC1GBA1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2326629-B1 SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INT (DE) 2013-10-02 EP disclosed
US-8178568-B2 Sulfone compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-15 US disclosed
US-8178568-B2 Sulfone compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-15 US disclosed
US-20110124696-A1 Sulfone Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-26 US disclosed
US-20110124696-A1 Sulfone Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-26 US disclosed
WO-2010005782-A1 SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124696-A1 Sulfone Compounds Which Modulate The CB2 Receptor CNR2, CNR1, TRPV1 FAAH 60/4885CDK5 1169/4885CDK5R1 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.